igf-1 lr3 subq or im Dosage: What to Know About Dosing, Safety, and Clinical Use About IGF-1R | Lonigutamab |
Description
Tulpule and Dringen 2013
McGrath KC, Li XH, Puranik R, Liong EC, Tan JT, Dy VM, DiBartolo BA, Barter PJ, Rye KA, Heather AK
doi: 10.1016/S0022-5223(19)32956-3
doi: 10.1007/s11010-014-2092-5
[DOI] [PMC free article] [PubMed] [Google Scholar] 34.Luo T., Shen X.Y., Li S., Ouyang T., Mai Q.A., Wang H.Q
The specificity of Ipamorelin makes this compound a very interesting candidate for future clinical development
